<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36511115</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Phosphorylation of enteroviral 2A<sup>pro</sup> at Ser/Thr125 benefits its proteolytic activity and viral pathogenesis.</ArticleTitle><Pagination><StartPage>e28400</StartPage><MedlinePgn>e28400</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e28400</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.28400</ELocationID><Abstract><AbstractText>Enteroviral 2A proteinase (2A<sup>pro</sup> ), a well-established and important viral functional protein, plays a key role in shutting down cellular cap-dependent translation, mainly via its proteolytic activity, and creating optimal conditions for Enterovirus survival. Accumulated data show that viruses take advantage of various signaling cascades for their life cycle; studies performed by us and others have demonstrated that the extracellular signal-regulated kinase (ERK) pathway is essential for enterovirus A71 (EV-A71) and other viruses replication. We recently showed that ERK1/2 is required for the proteolytic activity of viral 2A<sup>pro</sup> ; however, the mechanism underlying the regulation of 2A<sup>pro</sup> remains unknown. Here, we demonstrated that the 125th residue Ser125 of EV-A71 2A<sup>pro</sup> or Thr125 of coxsackievirus B3 2A<sup>pro</sup> , which is highly conserved in the Enterovirus, was phosphorylated by ERK1/2. Importantly, 2A<sup>pro</sup> with phosphor-Ser/Thr125 had much stronger proteolytic activity toward eukaryotic initiation factor 4GI and rendered the virus more efficient for multiplication and pathogenesis in hSCARB2 knock-in mice than that in nonphospho-Ser/Thr125A (S/T125A) mutants. Notably, phosphorylation-mimic mutations caused deleterious changes in 2A<sup>pro</sup> catalytic function (S/T125D/E) and in viral propagation (S125D). Crystal structure simulation analysis showed that Ser125 phosphorylation in EV-A71 2A<sup>pro</sup> enabled catalytic Cys to adopt an optimal conformation in the catalytic triad His-Asp-Cys, which enhances 2A<sup>pro</sup> proteolysis. Therefore, we are the first to report Ser/Thr125 phosphorylation of 2A<sup>pro</sup> increases enteroviral adaptation to the host to ensure enteroviral multiplication, causing pathogenicity. Additionally, weakened viruses containing a S/T125A mutation could be a general strategy to develop attenuated Enterovirus vaccines.</AbstractText><CopyrightInformation>© 2022 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yuya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Wenjia</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Microbiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Sanyuan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Bangtao</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Microbiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Microbiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Microbiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Zhijun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Jiangxi Provincial Key Laboratory of Tumor Pathogens and Molecular Pathology, Queen Mary School, Nanchang University Jiangxi Medical College, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Changfa</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Zhaohua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yihong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.29</RegistryNumber><NameOfSubstance UI="C057400">picornain 2A, Picornavirus</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059748" MajorTopicYN="N">Proteolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="Y">Viral Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">eIF4GI</Keyword><Keyword MajorTopicYN="N">enteroviral 2Apro</Keyword><Keyword MajorTopicYN="N">phosphorylation</Keyword><Keyword MajorTopicYN="N">proteolytic activity</Keyword><Keyword MajorTopicYN="N">viral pathogenesis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>13</Day><Hour>4</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36511115</ArticleId><ArticleId IdType="pmc">PMC10107306</ArticleId><ArticleId IdType="doi">10.1002/jmv.28400</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zell R, Delwart E, Gorbalenya AE, et al. ICTV virus taxonomy profile: picornaviridae. J Gen Virol. 2017;98(10):2421‐2422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5725991</ArticleId><ArticleId IdType="pubmed">28884666</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre CL, Knowles NJ, Simmonds P. Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types. J Gen Virol. 2013;94(Pt 8):1791‐1806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3749525</ArticleId><ArticleId IdType="pubmed">23677786</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer TK, Simmonds P, Harvala H. The importance of enterovirus surveillance in a post‐polio world. Lancet Infect Dis. 2022;22(1):e35‐e40.</Citation><ArticleIdList><ArticleId IdType="pubmed">34265258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Musharrafieh R, Zheng M, Wang J. Enterovirus D68 antivirals: past, present, and future. ACS Infect Dis. 2020;6(7):1572‐1586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8055446</ArticleId><ArticleId IdType="pubmed">32352280</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KS, Hufnagel G, Chapman NM, Tracy S. The group B coxsackieviruses and myocarditis. Rev Med Virol. 2001;11(6):355‐368.</Citation><ArticleIdList><ArticleId IdType="pubmed">11746998</ArticleId></ArticleIdList></Reference><Reference><Citation>Precechtelova J, Borsanyiova M, Sarmirova S, Bopegamage S. Type I diabetes mellitus: genetic factors and presumptive enteroviral etiology or protection. J Pathog. 2014;2014:738512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4276674</ArticleId><ArticleId IdType="pubmed">25574400</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Thibaut HJ, Strating JRPM, van Kuppeveld FJM. The life cycle of non‐polio enteroviruses and how to target it. Nat Rev Microbiol. 2018;16(6):368‐381.</Citation><ArticleIdList><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura N, Semler BL, Rothberg PG, et al. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature. 1981;291(5816):547‐553.</Citation><ArticleIdList><ArticleId IdType="pubmed">6264310</ArticleId></ArticleIdList></Reference><Reference><Citation>Lulla V, Dinan AM, Hosmillo M, et al. An upstream protein‐coding region in enteroviruses modulates virus infection in gut epithelial cells. Nat Microbiol. 2019;4(2):280‐292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6443042</ArticleId><ArticleId IdType="pubmed">30478287</ArticleId></ArticleIdList></Reference><Reference><Citation>Borman AM, Le Mercier P, Girard M, Kean KM. Comparison of picornaviral IRES‐driven internal initiation of translation in cultured cells of different origins. Nucleic Acids Res. 1997;25(5):925‐932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC146526</ArticleId><ArticleId IdType="pubmed">9023100</ArticleId></ArticleIdList></Reference><Reference><Citation>Kräusslich HG, Nicklin MJ, Toyoda H, Etchison D, Wimmer E. Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J Virol. 1987;61(9):2711‐2718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC255777</ArticleId><ArticleId IdType="pubmed">3039165</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K‐M, Chen C‐J, Shih S‐R. Regulation mechanisms of viral IRES‐driven translation. Trends Microbiol. 2017;25(7):546‐561.</Citation><ArticleIdList><ArticleId IdType="pubmed">28242053</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu SF, Lloyd RE. Identification of essential amino acid residues in the functional activity of poliovirus 2A protease. Virology. 1991;182(2):615‐625.</Citation><ArticleIdList><ArticleId IdType="pubmed">1850921</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelló A, Alvarez E, Carrasco L. The multifaceted poliovirus 2A protease: regulation of gene expression by picornavirus proteases. J Biomed Biotechnol. 2011;2011:369648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3085340</ArticleId><ArticleId IdType="pubmed">21541224</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Cheng A, Wang M, et al. Structures and corresponding functions of five types of picornaviral 2A proteins. Front Microbiol. 2017;8:1373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5519566</ArticleId><ArticleId IdType="pubmed">28785248</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R‐L, Chen C‐J, Wang RYL, et al. Role of enteroviral RNA‐dependent RNA polymerase in regulation of MDA5‐mediated beta interferon activation. J Virol. 2019;93(10):e00132‐19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6498057</ArticleId><ArticleId IdType="pubmed">30814289</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Xi X, Lei X, et al. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti‐viral type I interferon responses. PLoS Pathog. 2013;9(3):e1003231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Yi L, Zhao J, et al. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J Virol. 2012;86(7):3767‐3776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Wang Y, Pei X, Wang S, Zhang H, Peng Y. Cellular caspase‐3 contributes to EV‐A71 2Apro‐mediated down‐regulation of IFNAR1 at the translation level. Virol Sin. 2020;35(1):64‐72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7035401</ArticleId><ArticleId IdType="pubmed">31512106</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen KJ, Garmaroudi FS, Zhang J, et al. An ERK‐p38 subnetwork coordinates host cell apoptosis and necrosis during coxsackievirus B3 infection. Cell Host Microbe. 2013;13(1):67‐76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3553504</ArticleId><ArticleId IdType="pubmed">23332156</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H, Yanagawa B, Zhang J, et al. Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal‐regulated kinase (ERK) signaling pathway. J Virol. 2002;76(7):3365‐3373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136021</ArticleId><ArticleId IdType="pubmed">11884562</ArticleId></ArticleIdList></Reference><Reference><Citation>Pleschka S. RNA viruses and the mitogenic Raf/MEK/ERK signal transduction cascade. Biol Chem. 2008;389(10):1273‐1282.</Citation><ArticleIdList><ArticleId IdType="pubmed">18713014</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Zhang H, Zhu M, Luo Z, Peng Y. MEK1‐ERKs signal cascade is required for the replication of Enterovirus 71 (EV71). Antiviral Res. 2012;93(1):110‐117.</Citation><ArticleIdList><ArticleId IdType="pubmed">22101247</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MC, Dobrikov MI, Gromeier M. Mitogen‐activated protein kinase‐interacting kinase regulates mTOR/AKT signaling and controls the serine/arginine‐rich protein kinase‐responsive type 1 internal ribosome entry site‐mediated translation and viral oncolysis. J Virol. 2014;88(22):13149‐13160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4249080</ArticleId><ArticleId IdType="pubmed">25187540</ArticleId></ArticleIdList></Reference><Reference><Citation>Jheng J‐R, Wang S‐C, Jheng C‐R, Horng J‐T. Enterovirus 71 induces dsRNA/PKR‐dependent cytoplasmic redistribution of GRP78/BiP to promote viral replication. Emerg Microbes Infect. 2016;5:1‐12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4820672</ArticleId><ArticleId IdType="pubmed">27004760</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Sun M, Yuan X, et al. Enterovirus 71 suppresses interferon responses by blocking Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling through inducing karyopherin‐α1 degradation. J Biol Chem. 2017;292(24):10262‐10274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5473229</ArticleId><ArticleId IdType="pubmed">28455446</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan H, Zhu M, Xiong Q, et al. Regulation of enterovirus 2A protease‐associated viral IRES activities by the cell's ERK signaling cascade: implicating ERK as an efficiently antiviral target. Antiviral Res. 2017;143:13‐21.</Citation><ArticleIdList><ArticleId IdType="pubmed">28351508</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Wang X, Wang Y, et al. Substituted 3‐benzylcoumarins 13 and 14 suppress enterovirus A71 replication by impairing viral 2Apro dependent IRES‐driven translation. Antiviral Res. 2018;160:10‐16.</Citation><ArticleIdList><ArticleId IdType="pubmed">30315876</ArticleId></ArticleIdList></Reference><Reference><Citation>Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK‐activated protein kinases. Microbiol Mol Biol Rev. 2011;75(1):50‐83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3063353</ArticleId><ArticleId IdType="pubmed">21372320</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon S, Seger R. The extracellular signal‐regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors. 2006;24(1):21‐44.</Citation><ArticleIdList><ArticleId IdType="pubmed">16393692</ArticleId></ArticleIdList></Reference><Reference><Citation>Imura A, Sudaka Y, Takashino A, et al. Development of an enterovirus 71 vaccine efficacy test using human scavenger receptor B2 transgenic mice. J Virol. 2020;94(6):e01921‐19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158731</ArticleId><ArticleId IdType="pubmed">31896594</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q, Yameen M, Liu W, et al. Conformational plasticity of the 2A proteinase from enterovirus 71. J Virol. 2013;87(13):7348‐7356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3700279</ArticleId><ArticleId IdType="pubmed">23616646</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazan JF, Fletterick RJ. Viral cysteine proteases are homologous to the trypsin‐like family of serine proteases: structural and functional implications. Proc Natl Acad Sci USA. 1988;85(21):7872‐7876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC282299</ArticleId><ArticleId IdType="pubmed">3186696</ArticleId></ArticleIdList></Reference><Reference><Citation>Pleschka S, Wolff T, Ehrhardt C, et al. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nature Cell Biol. 2001;3(3):301‐305.</Citation><ArticleIdList><ArticleId IdType="pubmed">11231581</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemonnot B, Cartier C, Gay B, et al. The host cell MAP kinase ERK‐2 regulates viral assembly and release by phosphorylating the p6 protein of HIV‐1. J Biol Chem. 2004;279(31):32426‐32434.</Citation><ArticleIdList><ArticleId IdType="pubmed">15155723</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichwald C, Jacob G, Muszynski B, Allende JE, Burrone OR. Uncoupling substrate and activation functions of rotavirus NSP5: phosphorylation of Ser‐67 by casein kinase 1 is essential for hyperphosphorylation. Proc Natl Acad Sci USA. 2004;101(46):16304‐16309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC528968</ArticleId><ArticleId IdType="pubmed">15520389</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahariadis G, Wagner MJ, Doepker RC, et al. Cell‐type‐specific tyrosine phosphorylation of the herpes simplex virus tegument protein VP11/12 encoded by gene UL46. J Virol. 2008;82(13):6098‐6108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2447066</ArticleId><ArticleId IdType="pubmed">18417566</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya D, Mayuri I, Best SM, Perera R, Kuhn RJ, Striker R. Protein kinase G phosphorylates mosquito‐borne flavivirus NS5. J Virol. 2009;83(18):9195‐9205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2738234</ArticleId><ArticleId IdType="pubmed">19587048</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Yang X, Zhao Z, Liu X, Zhang W. Host restriction factor A3G inhibits the replication of enterovirus D68 by competitively binding the 5' untranslated region with PCBP1. J Virol. 2022;96(2):e0170821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8791300</ArticleId><ArticleId IdType="pubmed">34730395</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002;298(5600):1912‐1934.</Citation><ArticleIdList><ArticleId IdType="pubmed">12471243</ArticleId></ArticleIdList></Reference><Reference><Citation>Steichen JM, Iyer GH, Li S, et al. Global consequences of activation loop phosphorylation on protein kinase A. J Biol Chem. 2010;285(6):3825‐3832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2823524</ArticleId><ArticleId IdType="pubmed">19965870</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitmarsh AJ, Davis RJ. Multisite phosphorylation by MAPK. Science. 2016;354(6309):179‐180.</Citation><ArticleIdList><ArticleId IdType="pubmed">27738159</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, He YS, Kim Y, et al. The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. J Virol. 1997;71(1):405‐411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191065</ArticleId><ArticleId IdType="pubmed">8985364</ArticleId></ArticleIdList></Reference><Reference><Citation>Modrof J, Möritz C, Kolesnikova L, et al. Phosphorylation of Marburg virus VP30 at serines 40 and 42 is critical for its interaction with NP inclusions. Virology. 2001;287(1):171‐182.</Citation><ArticleIdList><ArticleId IdType="pubmed">11504552</ArticleId></ArticleIdList></Reference><Reference><Citation>Newsome TP, Weisswange I, Frischknecht F, Way M. Abl collaborates with Src family kinases to stimulate actin‐based motility of vaccinia virus. Cell Microbiol. 2006;8(2):233‐241.</Citation><ArticleIdList><ArticleId IdType="pubmed">16441434</ArticleId></ArticleIdList></Reference><Reference><Citation>Leong SY, Ong BKT, Chu JJH. The role of Misshapen NCK‐related kinase (MINK), a novel Ste20 family kinase, in the IRES‐mediated protein translation of human enterovirus 71. PLoS Pathog. 2015;11(3):e1004686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4352056</ArticleId><ArticleId IdType="pubmed">25747578</ArticleId></ArticleIdList></Reference><Reference><Citation>Stork J, Panaviene Z, Nagy PD. Inhibition of in vitro RNA binding and replicase activity by phosphorylation of the p33 replication protein of cucumber necrosis tombusvirus. Virology. 2005;343(1):79‐92.</Citation><ArticleIdList><ArticleId IdType="pubmed">16154612</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonemoto W, McGlone ML, Grant B, Taylor SS. Autophosphorylation of the catalytic subunit of cAMP‐dependent protein kinase in Escherichia coli . Protein Eng Des Sel. 1997;10(8):915‐925.</Citation><ArticleIdList><ArticleId IdType="pubmed">9415441</ArticleId></ArticleIdList></Reference><Reference><Citation>McClendon CL, Kornev AP, Gilson MK, Taylor SS. Dynamic architecture of a protein kinase. Proc Natl Acad Sci USA. 2014;111(43):E4623‐E4631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4217441</ArticleId><ArticleId IdType="pubmed">25319261</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>